Prevention and Treatment of Diabetes in Adults
NCT04832984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91
Last updated 2024-11-22
Summary
Currently, an estimated 3.9 million Malaysians continue to live with diabetes with many more who live with prediabetes. Diabetes was the one of the leading causes of death in the Malaysia and the leading cause for kidney failure, lower-limb amputations, and adult-onset blindness. Heart disease and stroke are two to four times more likely for individuals with diabetes. The use of mHealth or mobile health application can reduce blood sugar among individuals with prediabetes but also prevent a later occurrence of diabetes. In this study, the investigators aim to develop and evaluate the effectiveness of a digital health supported pre-diabetes management program based in an urban community pharmacy setting
Conditions
Interventions
- BEHAVIORAL
-
Mobile health
Participants will be issued a fitness tracker, Bluetooth enabled glucometer, and a custom developed app which they can communicate digitally to the study investigators either as a group or individually. In the beginning of the study, participants will be taught on how to use the program, how to interact with their coach, and the importance of maintaining motivation throughout the program. Participants will have access to a pharmacist-participant messaging, group messaging, daily challenges for behavior change, education articles (biweekly bite-sized content over 24 weeks), food logging, steps and exercise logging, and feedback. They will be asked to log their weight, meals, and physical activity within the program on a weekly basis. Pharmacist will monitor participant progress through a web-based dashboard. Community pharmacist will be assisting users in setting specific, measurable, attainable, realistic, and time-based goals on a weekly basis.
- BEHAVIORAL
-
Usual care
Participants will be issued a fitness tracker and Bluetooth enabled glucometer but these functions will not be enabled or linked to any app. All participants will be given physical tracking sheets to log in their food intake, blood glucose levels and food diary but will not have access to a personal coaching. Participants are free to seek any assistance for their medical care during the study period.
Sponsors & Collaborators
-
Caring Pharmacy
collaborator UNKNOWN -
Bionime Corporation
collaborator INDUSTRY -
Tigas Pharma
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Shaun Lee · Monash University Malaysia
-
Chun Wie Chong · Monash University Malaysia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-23
- Primary Completion
- 2024-06-15
- Completion
- 2024-06-30
Countries
- Malaysia
Study Locations
More Related Trials
-
Diabetes Care Programme for Type 2 Diabetes Mellitus in Primary Care Setting
NCT04348565 ·Status: UNKNOWN ·Phase: NA
-
The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program
NCT03503942 ·Status: COMPLETED ·Phase: NA
-
Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships
NCT07043426 ·Status: RECRUITING ·Phase: NA
-
The Effect of Remote SMBG Combined With the Application of APP on the Improvement of T2DM Management in the Community
NCT03588000 ·Status: COMPLETED ·Phase: NA
-
Evaluating an Analogy-Based Consultation Approach for Insulin-Treated Type 2 Diabetes Patients
NCT07265245 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129 ·Status: RECRUITING
-
Asian Diabetes Surgery Study (ADSS): Clinical Predictor for the Success of Metabolic Surgery
NCT01317979 ·Status: UNKNOWN
-
Establishment and Preliminary Evaluation of Digital Three Level Linkage Whole Process Diabetes Management System
NCT04999722 ·Status: UNKNOWN ·Phase: NA
-
A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia
NCT01934673 ·Status: COMPLETED
-
Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin
NCT00169624 ·Status: TERMINATED ·Phase: PHASE3
-
A Randomized Trial to Slow the Progression of Diabetes
NCT03800680 ·Status: COMPLETED ·Phase: NA
-
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
NCT02226822 ·Status: COMPLETED
-
Personalized Medicine for Diabetes Prediction and Prevention of Complications
NCT01268813 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by a Diabetes Specialist Team
NCT01690208 ·Status: UNKNOWN ·Phase: NA
-
Observational Study of ASCVD Risks of Type 2 Diabetes in East China
NCT04866667 ·Status: COMPLETED
-
Establishment of Precise Nutrition Management Scheme for Patients With Prediabetes Based on Nutrigenomics
NCT06335225 ·Status: RECRUITING ·Phase: NA
-
The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
NCT06843304 ·Status: RECRUITING
-
Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control
NCT00021944 ·Status: COMPLETED
-
Metabolic Syndrome and Prediabetes
NCT07243821 ·Status: RECRUITING
-
Prediabetes and Metabolic Parameters Among Young Adults at Assiut University Hospital
NCT07259954 ·Status: NOT_YET_RECRUITING
-
Dietary Intervention in Diabetes Mellitus (DIDM)- Intermediate and Acute Effects
NCT01585818 ·Status: UNKNOWN ·Phase: PHASE2
-
Development of Minimally Invasive Methodology for Diabetyping to Personalise Treatment to Realise Remission and Reversal of Type 2 Diabetes
NCT06125119 ·Status: RECRUITING
-
Precise Treatment of Prediabetes and Stage 1 Hypertension
NCT04529590 ·Status: COMPLETED
-
Pharmaceutical Care Program for Type 2 Diabetes Mellitus
NCT02435693 ·Status: COMPLETED ·Phase: NA
-
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
NCT05369065 ·Status: RECRUITING ·Phase: PHASE1